Agiostratidou Georgia, Li Maomi, Suyama Kimita, Badano Ines, Keren Rinat, Chung Su, Anzovino Amy, Hulit James, Qian Binzhi, Bouzahzah Boumediene, Eugenin Eliseo, Loudig Olivier, Phillips Greg R, Locker Joseph, Hazan Rachel B
Department of Pathology, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
Cancer Res. 2009 Jun 15;69(12):5030-8. doi: 10.1158/0008-5472.CAN-08-4007. Epub 2009 Jun 2.
The mammary epithelium is thought to be stabilized by cell-cell adhesion mediated mainly by E-cadherin (E-cad). Here, we show that another cadherin, retinal cadherin (R-cad), is critical for maintenance of the epithelial phenotype. R-cad is expressed in nontransformed mammary epithelium but absent from tumorigenic cell lines. In vivo, R-cad was prominently expressed in the epithelium of both ducts and lobules. In human breast cancer, R-cad was down-regulated with tumor progression, with high expression in ductal carcinoma in situ and reduced expression in invasive duct carcinomas. By comparison, E-cad expression persisted in invasive breast tumors and cell lines where R-cad was lost. Consistent with these findings, R-cad knockdown in normal mammary epithelium stimulated invasiveness and disrupted formation of acini despite continued E-cad expression. Conversely, R-cad overexpression in aggressive cell lines induced glandular morphogenesis and inhibited invasiveness, tumor formation, and lung colonization. R-cad also suppressed the matrix metalloproteinase 1 (MMP1), MMP2, and cyclooxygenase 2 gene expression associated with pulmonary metastasis. The data suggest that R-cad is an adhesion molecule of the mammary epithelium, which acts as a critical regulator of the normal phenotype. As a result, R-cad loss contributes to epithelial suppression and metastatic progression.